Stocks and Investing Stocks and Investing
Thu, October 28, 2021
Wed, October 27, 2021

Robert Driscoll Maintained (ZNTL) at Buy with Increased Target to $89 on, Oct 27th, 2021


Published on 2024-10-27 18:21:47 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $65 to $89 on, Oct 27th, 2021.

Robert has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Robert's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Robert


  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $84 on, Thursday, September 30th, 2021
  • Matthew Biegler of "Oppenheimer" Initiated at Buy and Held Target at $90 on, Wednesday, September 29th, 2021
Contributing Sources